Navigation Links
Inovio Pharmaceuticals to Present at OneMedForumNY 2013 Investor Conference
Date:6/20/2013

ty of Manitoba and PATH Malaria Vaccine Initiative. More information is available at www.inovio.com.

This press release contains certain forward-looking statements relating to our business, including our plans to develop electroporation-based drug and gene delivery technologies and DNA vaccines and our capital resources. Actual events or results may differ from the expectations set forth herein as a result of a number of factors, including uncertainties inherent in pre-clinical studies, clinical trials and product development programs (including, but not limited to, the fact that pre-clinical and clinical results referenced in this release may not be indicative of results achievable in other trials or for other indications, that the studies or trials may not be successful or achieve the results desired, that pre-clinical studies and clinical trials may not commence or be completed in the time periods anticipated, that results from one study may not necessarily be reflected or supported by the results of other similar studies and that results from an animal study may not be indicative of results achievable in human studies), the availability of funding to support continuing research and studies in an effort to prove safety and efficacy of electroporation technology as a delivery mechanism or develop viable DNA vaccines, the adequacy of our capital resources, the availability or potential availability of alternative therapies or treatments for the conditions targeted by the company or its collaborators, including alternatives that may be more efficacious or cost-effective than any therapy or treatment that the company and its collaborators hope to develop, evaluation of potential opportunities, issues involving product liability, issues involving patents and whether they or licenses to them will provide the company with meaningful protection from others using the covered technologies, whether such proprietary rights are e
'/>"/>

SOURCE Inovio Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Inovios Universal H7N9 DNA Vaccine Generates First Protective Antibody Responses Against Virulent H7N9 Virus in 100% of Vaccinated Animals
2. Inovio Pharmaceuticals DNA Vaccine Against Ebola and Marburg Filoviruses Provides Complete Protection in Preclinical Challenge Study
3. Inovio Pharmaceuticals Universal H1N1 Influenza Vaccine Achieves Protective Immune Responses Comparable to Conventional Vaccine in Phase I Study
4. Inovio Pharmaceuticals Recognized With "Best Therapeutic Vaccine" and "Best Early Stage Biotech" Awards at World Vaccine Congress 2013
5. Inovio Pharmaceuticals & U.S. Army Receive $3.5 Million Biodefense Grant to Further Develop Mass Vaccination Device
6. Inovio Collaborator ChronTech Reports Interim Phase II Clinical Study Results from ChronVac-C Vaccine for Hepatitis C Infection
7. Inovio Pharmaceuticals to Present at BioCenturys "Future Leaders in the Biotech Industry" Conference
8. Inovio Pharmaceuticals Reports 2012 Fourth Quarter and Year End Financial Results
9. Morning Research on Sequenom, Peregrine Pharma, Onyx Pharma, and Inovio Pharma
10. Inovio Pharmaceuticals Closes $15.1 Million Offering of Common Stock and Warrants
11. Inovio Pharmaceuticals Prices $15.1 Million Offering of Common Stock and Warrants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... July 6, 2015   BioClinica®, Inc ., ... today announced that it has acquired a leading ... , Inc. (Medici).  The acquisition includes affiliates ... Medici also provides a lost-to-follow-up patient locate service ...  Together with Medici, BioClinica will offer ...
(Date:7/6/2015)... 2015 Cardinal Health today announced the completion ... distributor of generic pharmaceuticals, over-the-counter medications and related products ... owned by Court Square Capital Partners. The $1.115 billion ... new debt.  Headquartered in ... revenues of approximately $450 million in 2014. There are ...
(Date:7/6/2015)... , July 6, 2015 E-QURE Corp (OTCQB: ... present live at VirtualInvestorConferences.com on July 9, 2015. ... http://tinyurl.com/e-qure-presentation This will be ... to ask the company questions in real-time - both ... "virtual trade booth." If attendees are not able to ...
Breaking Medicine Technology:BioClinica Acquires MediciGroup 2BioClinica Acquires MediciGroup 3Cardinal Health Completes Acquisition Of The Harvard Drug Group For $1.115 Billion 2Cardinal Health Completes Acquisition Of The Harvard Drug Group For $1.115 Billion 3E-QURE Corp to Webcast, Live, at VirtualInvestorConferences.com July 9 2
... Ga., June 14, 2011 Cardinal Health today opened ... further expanding its nationwide capability to manufacture molecular imaging ... treatment of cancer, neurological disorders and heart disease. ... Positron Emission Tomography (PET) molecular imaging agents, one of ...
... June 14, 2011 Orthopedics This Week announced today ... News to supply Orthopedics This Week, the #1 source ... terminal subscribers including some of the most prominent investors ... The Bloomberg network includes portfolio managers, central bankers, finance ...
Cached Medicine Technology:Cardinal Health Extends Radiopharmaceutical Manufacturing Network, Opening its First Cyclotron in Georgia 2Cardinal Health Extends Radiopharmaceutical Manufacturing Network, Opening its First Cyclotron in Georgia 3Orthopedics This Week Now on Bloomberg 2
(Date:7/6/2015)... Pompano Beach, Florida (PRWEB) , ... July 06, ... ... call center solutions, announced today that Randstad Technologies selected Aspect Software Unified IP ... provider in the United States, selected Aspect Unified IP as its future call ...
(Date:7/6/2015)... ... July 06, 2015 , ... Diabetes affects many of us ... 29 million Americans have diabetes, the majority of which are Type 2. However, eight ... more than one in three, have prediabetes (abnormally high blood sugar levels). Without reductions ...
(Date:7/6/2015)... ... July 06, 2015 , ... The Path of Least Resistance: The Evolution ... associated with the U.S. economy over the past 40 years. The book explores the ... many ways, the book is a time capsule that chronicles the economic development of ...
(Date:7/5/2015)... ... July 06, 2015 , ... City Sports, the Boston-based specialty ... co-produce two training clinics for first-time triathletes this summer with ethos, the owner and ... on Thursday, July 9, at 6:00 p.m. at the North End Greenway. The event ...
(Date:7/5/2015)... ... July 05, 2015 , ... ... the Weed Master, a landscaping invention that effectively removes weeds without harming ... dollars," says Scott Cooper, CEO and Creative Director of World Patent Marketing. "It ...
Breaking Medicine News(10 mins):Health News:Aspect Software Unified IP, Hosted by Promero, Selected by Randstad Technologies 2Health News:Aspect Software Unified IP, Hosted by Promero, Selected by Randstad Technologies 3Health News:115 Million in the U.S. could beat diabetes with the help of a new app 2Health News:New Book Brings Reveals The Repercussions Associated With The Global Economy 2Health News:Sporting Goods Retailer City Sports Renews Partnership with Boston Triathlon 2Health News:Sporting Goods Retailer City Sports Renews Partnership with Boston Triathlon 3Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 2Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 3Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 4Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 5
... Psoriasis Cure Now,a nonprofit patient advocacy group, responded ... severe psoriasis and a significantly,increased risk of death, ... by a team of University of Pennsylvania School ... a 50 percent,increased risk of mortality as compared ...
... Dec. 18 Stryker Corporation,(NYSE: SYK ) announced ... January 8, 2008 - 2:30 p.m. Pacific ... Francisco, California, January 30, 2008 - 10:45 a.m. ... Simultaneous webcasts of the Company,s presentations will be ...
... Recognizes MedcomSoft ... ATLANTA, GA, Dec. 18 /PRNewswire-FirstCall/ - MedcomSoft Inc.,(TSX-MSF), ... records (EHR), announced today that KLAS, "2007: Top 20 ... KLAS" in the Ambulatory,EMR 1-5 Physicians category. MedcomSoft retains ...
... suffering from Chronic Fatigue Syndrome (CFS) is that many ... affliction. , New research by the Faculty of Kinesiology ... symptoms information that could help doctors in the ... eliminating every other possible cause, which leads some to ...
... last few years much ballyhooed lunch hour and ... rejuvenation are expected to pursue more reliably effective ... Jeffrey Spiegel, MD, chief of facial plastic and ... and Boston Medical Center, people are frustrated ...
... December 18, 2007 New information published in the ... for using or not using cannabis and found various ... Griffith University in Australia administered a survey to students ... the advantages and disadvantages of using cannabis, their perceptions ...
Cached Medicine News:Health News:Stryker to Present at Investor Conferences 2Health News:MedcomSoft Receives 2007's "Best in KLAS" EMR Ranking (1-5 Physicians) 2Health News:MedcomSoft Receives 2007's "Best in KLAS" EMR Ranking (1-5 Physicians) 3Health News:Researchers hope to provide chronic fatigue syndrome answers 2Health News:Significant changes in plastic surgery expected in 2008 2Health News:Significant changes in plastic surgery expected in 2008 3
... implant is a combination of innovative design, ... makes TheraSeed® treatment an ideal choice for ... that every TheraSeed® implant order is backed ... required by clinicians who must meet the ...
ACMI™ Double-J Closed Tip Ureteral Stents feature patented dual durometer thermosensitive Tecoflex® construction for physician ease of placement and patient comfort....
Used for retrograde positioning of a ureteral stent. The radiopaque band improves fluoroscopic visibility of the positioner tip. Supplied sterile in peel-open packages. Intended for one-time use....
... for interoperative placement to stent ... construction and continent urinary diversions. ... Intended for one-time use. CAUTION: ... must not remain indwelling more ...
Medicine Products: